SWAN Vs. IGLB: Which Helped You Sleep Better At Night?

Damir Khabirov/iStock via Getty Images On our last coverage of Amplify BlackSwan Growth & Treasury Core ETF (NYSEARCA:SWAN) we were less than thrilled with the setup and suggested investors should use the opportunity to move to another fund. Yes, while they may move differently at times than your other holdings, they don’t offer any advantage….

Read More

IGIB ETF: Just The Right Amount Of Duration And Credit Risk

tadamichi Investing in fixed-income securities, particularly corporate bonds, is an essential part of diversifying one’s investment portfolio. And it becomes a lot easier when the Fed isn’t raising rates. That’s one reason the iShares 5-10 Year Investment Grade Corporate Bond ETF (IGIB) is worth a look. IGIB is an exchange-traded fund that primarily invests in…

Read More

L3Harris Technologies: My Top Investment In 2024 (NYSE:LHX)

Egorych/E+ via Getty Images L3Harris Technologies (NYSE:LHX) is well-positioned to benefit from increased global defense spending amid geopolitical tensions, shows strong growth in its Space and Airborne Systems segment, is reducing debt and targeting significant organic growth and free cash flow, and is undervalued compared to peers, offering an attractive investment opportunity. A recent investor…

Read More

Roivant Sciences: Why Its ‘Vant’ Biotech Model Is A Buy (NASDAQ:ROIV)

gorodenkoff Roivant Sciences Ltd. (NASDAQ:ROIV) is a pioneering biotech focused on inflammation and immunology that operates with an innovative business model through its subsidiaries. Each company in the Roivant family specializes in specific therapeutic areas such as immuno-dermatology, autoimmune disorders, RNA therapies, blood diseases, clinical trials intelligence, and AI for drug discovery and development. Notable…

Read More

Moderna’s Flu/COVID Vaccine Prospects Are Undervalued By The Market (NASDAQ:MRNA)

Jelena Stanojkovic/iStock via Getty Images At a Glance Delving into Moderna’s (NASDAQ:MRNA) trajectory, my earlier analysis shed light on its eclectic project range. This spectrum spans from oncology to infectious diseases, with notable breakthroughs in RSV and flu vaccines. Moderna has since leaped forward, especially with mRNA-1083. This vaccine, both innovative and dual-purpose, targets COVID-19…

Read More

Deutsche Bank: Not Much Upside Ahead (NYSE:DB)

franz12 Deutsche Bank (NYSE:DB) has improved its performance in recent quarter supported by rising rates, a trend that is expected to reverse in the near future. While its shares remain cheap compared to other European banks, this is justified by the bank’s low profitability level. As I’ve covered in a previous article, Deutsche Bank is…

Read More

My Top 3 Stock Picks For 2024

Richard Drury In 2023, the stock market made an impressive recovery from one of its worst years in over a decade, which occurred in 2022. However, the journey for us investors hasn’t been smooth. Amid worries about inflation, escalating interest rates, an unforeseen crisis in regional banking, and escalating global tensions such as conflicts in…

Read More

IUS: A Good Core Equity Replacement (NASDAQ:IUS)

ardasavasciogullari Smart Beta ETFs are a type of investment fund that uses alternative index construction rules instead of the traditional market capitalization-weighted indices. Smart Beta strategies seek to passively follow indices while also taking advantage of certain active investment strategies to improve returns, manage risks, or increase diversification. Smart Beta ETFs are becoming increasingly popular…

Read More

Southwestern Energy: Is A Merger Worth It? (NYSE:SWN)

Chun han There are rumors floating around that Southwestern Energy (NYSE:SWN) is considering a merger with Chesapeake (CHK). As I have discussed in the past, both managements could use a serious upgrade. But there are attractions in that these companies operate in both the Marcellus and the Haynesville. So, there could be some attraction in…

Read More

Carisma Therapeutics: New Frontiers In Cell Therapy, But Too Early To Buy In (NASDAQ:CARM)

ffikretow Topline Summary Carisma Therapeutics (NASDAQ:CARM), formerly Sesen Bio, is a developmental biotech exploring the potential of cell therapies for cancer management. They hope that by exploiting immune cells called macrophages that they can continue to push the field of cell therapies forward. But cash concerns and limited clinical trial data make this something difficult…

Read More

Portman Ridge Finance: A Complicated 15% Dividend At 18.5% Discount To NAV (NASDAQ:PTMN)

poco_bw/iStock via Getty Images Portman Ridge Finance (NASDAQ:PTMN) is a small externally managed business development company investing in middle market businesses using a range of financing structures from first lien loans to subordinated debt and equity co-investment. The BDC is broadly sector-neutral with investments in tech firms, food and beverage businesses, and pharmaceuticals. A fully…

Read More

46 Ideal 2024 Fortune And Barron’s DiviDogs

edb3_16 Foreword This article is based on three Fortune and Barron’s articles, describing the top 100 of Euro Fortune 500, Inflation Proof, and Barron’s Top stocks for 2024. The title and links to the articles follow: Fortune 500 Europe (Top 100) In raw statistical terms, Europe’s economy trails those of the U.S. and China. But…

Read More

JPMorgan Vs. Bank of America Vs. Wells Fargo

Michael Nagle Thesis In this article, I will conduct a comparison among JPMorgan Chase & Co. (JPM), Bank of America Corporation (BAC), and Wells Fargo & Company (WFC). The valuation of the three largest U.S. banks reveals that JPMorgan is poised to outperform the other two, boasting a fair price per share of approximately $314.74….

Read More

Energizer Still Has Power To Move Higher (NYSE:ENR)

JHVEPhoto/iStock Editorial via Getty Images Beyond any doubt, one of the most iconic consumer brands in the world today has got to be Energizer Holdings (NYSE:ENR). Although the firm is not that large, with a market capitalization of only $2.29 billion, it is well known as a giant in the battery production space, particularly when…

Read More

Iron Mountain: Expensive Relative To Other REITs (NYSE:IRM)

Settapongd Dee-ud/iStock via Getty Images Dear readers, Iron Mountain Incorporated (NYSE:IRM) is a data storage REIT focused on innovative solutions in data center infrastructure, asset lifecycle management, and information management services. The REIT primarily owns two distinct types of properties – paper storage facilities and data centers. While the former is likely to experience a…

Read More

Australian regulator steps up greenwashing crackdown

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Australia’s corporate watchdog has pledged to continue to crack down on misleading environmental claims made by funds this year after it launched legal action against three in 2023.  Sarah Court, deputy chair of the Australian…

Read More

Up To 10% Yields: My Top 10 High Dividend Yield Companies For January 2024

Userba011d64_201/iStock via Getty Images Investment Thesis The inclusion of high dividend yield companies in your investment portfolio demands a discerning selection process. Those companies, which pay sustainable dividends, are crucial for your overall investment portfolio, given their lower risk level and their ability to provide a stable and predictable dividend income stream. Companies that pay…

Read More